Dry powder type polyacrylamide solution constant-temperature heating device and sewage desliming system
By designing a dry powder polyacrylamide solution constant temperature heating device in the sewage desludge system, and using an electric heating device and heat exchange chamber to heat the solution evenly, the poor solubility of polyacrylamide caused by low water temperature in winter is solved, and the agent list is reduced Consumption and production costs improve sewage treatment efficiency.
Patent Information
- Application Number
- CN202420051970.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-09
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2034-01-09
AI Technical Summary
In the sewage desludge system, low water temperature in winter leads to a reduced solubility of dry powder polyacrylamide, forming flocs, resulting in high drug consumption and blockage of pipelines. The existing technology is difficult to effectively solve this problem.
A dry powder polyacrylamide solution constant temperature heating device is designed, including an electric heating device, a medium heating chamber, a heat exchange chamber, a medicine dosing box, a temperature sensor, a liquid level sensor and a PLC control box, and the medium heating chamber is heated through an electric heating device. The heat exchange medium in the heat exchange chamber is heated evenly to heat the solution in the dosing chamber, and the temperature of the polyacrylamide solution is controlled to be around 30°C to ensure the best dissolution effect.
It effectively solves the problems of low solubility and high drug consumption at low temperatures, reduces the amount of drug used, reduces production costs, avoids the risk of corrosion failure and leakage of heating pipes, achieves uniform heating, and improves Sewage treatment efficiency.
Smart Images

Figure CN221950965U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to a solution constant temperature heating device, in particular to a dry powder type polyacrylamide solution constant temperature heating device and a sewage desludging system. Background Art
[0002] In the current sewage desludging system, the water temperature is low in winter, which has a great impact on the solubility of dry powder polyacrylamide. The low water temperature will cause the solubility of dry powder polyacrylamide to be greatly reduced, forming flocs, not participating in desludging, resulting in high drug consumption and clogging of pipelines. Utility Model Content
[0003] In view of the defects in the prior art, the purpose of the utility model is to provide a dry powder polyacrylamide solution constant temperature heating device and a sewage desludging system.
[0004] According to the utility model, a dry powder polyacrylamide solution constant temperature heating device is provided, comprising: an electric heating device, a medium heating chamber, a heat exchange chamber, a dosing box, a temperature sensor, a liquid level sensor and a PLC control box;
[0005] The heat exchange cavity is arranged outside the medicine adding box, the heat exchange cavity is connected to the electric heating device, and the medium heating cavity is arranged between the electric heating device and the heat exchange cavity;
[0006] The temperature sensor and the liquid level sensor are installed on one side of the medicine adding box, and the temperature sensor and the liquid level sensor are connected to the PLC control box.
[0007] Preferably, a water inlet pipe is installed on the medicine adding box, a solenoid valve is arranged on the water inlet pipe, and the solenoid valve is connected to the PLC control box.
[0008] Preferably, a drain pipe is provided at the bottom of the heat exchange chamber, and a drain valve is installed on the drain pipe.
[0009] Preferably, an agitator and a dry powder dosing device are installed on the dosing box, and the agitator and the dry powder dosing device are connected to the PLC control box.
[0010] Preferably, a discharge pipe is provided at the bottom of the medicine adding box, and a valve is installed on the discharge pipe.
[0011] Preferably, a monitoring instrument is installed outside the medicine adding box, and the line inlet of the monitoring instrument is electrically connected to the temperature sensor.
[0012] Preferably, an exhaust pipe is provided on the heat exchange chamber, and a pressure relief valve is installed on the exhaust pipe.
[0013] Preferably, a medium water supply pipe is provided on the heat exchange chamber, and a plugging cover is installed on the medium water supply pipe.
[0014] Preferably, the stirrer is composed of a motor, a rotating shaft and blades;
[0015] The motor is mounted on the medicine adding box, the output end of the motor is connected to the rotating shaft, the rotating shaft extends to the inside of the medicine adding box, the blades are mounted on the rotating shaft, and the blades are located in the medicine adding box.
[0016] Compared with the prior art, the utility model has the following beneficial effects:
[0017] The utility model heats the heat exchange medium in the medium heating chamber by an electric heating device. After the heat exchange medium is heated, the solution in the dosing box is heated by the heat exchange chamber, thereby avoiding local overheating of the solution in the dosing box and making the internal solution heated more evenly, solving the problems of low solubility of dry powder polyacrylamide at low temperatures and high unit consumption of reagents. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Other features, objects and advantages of the present invention will become more apparent by reading the detailed description of non-limiting embodiments with reference to the following drawings:
[0019] Figure 1 It is a schematic diagram of the heating device structure;
[0020] Figure 2 This is a schematic diagram of the installation location of the monitoring device;
[0021] As shown in the figure:
[0022] DETAILED DESCRIPTION
[0023] The utility model is described in detail below in conjunction with specific embodiments. The following embodiments will help those skilled in the art to further understand the utility model, but do not limit the utility model in any form. It should be pointed out that for those of ordinary skill in the art, several changes and improvements can be made without departing from the concept of the utility model. These all belong to the protection scope of the utility model.
[0024] Example 1
[0025] like Figure 1 and Figure 2As shown, this embodiment provides a dry powder polyacrylamide solution constant temperature heating device for a sewage desludging system, including: an electric heating device 1, a medium heating chamber 2, a heat exchange chamber 3, a dosing box 4, a pressure relief valve 5, an exhaust pipe 6, a drain valve 7, a drain pipe 8, a medium water adding pipe 9, a plugging cover 10, a temperature sensor 11, a liquid level sensor 12, a PLC control box 13, a dry powder dosing device 14, an agitator 15, a water inlet pipe 16, a solenoid valve 17, a discharge pipe 18, a valve 19 and a monitoring instrument 20.
[0026] A heat exchange chamber 3 is arranged on the outer side of the side and bottom of the dosing box 4, the heat exchange chamber 3 is connected to the electric heating device 1, and a medium heating chamber 2 is arranged between the electric heating device 1 and the heat exchange chamber 3; the electric heating device 1 heats the heat exchange medium in the medium heating chamber 2, and after the heat exchange medium is heated, the solution in the dosing box 4 is heated through the heat exchange chamber 3.
[0027] A temperature sensor 11 and a liquid level sensor 12 are installed on the top of the dosing box 4, and a monitor 20 is installed outside the dosing box 4. The inlet end of the monitor 20 is electrically connected to the temperature sensor 11. The temperature sensor 11 is used to measure the temperature and feed it back to the PLC control box 13 and the monitor 20, and the liquid level sensor 12 is used to measure the liquid level.
[0028] The dosing box 4 is provided with a water inlet pipe 16 for adding liquid into the dosing box 4, and a solenoid valve 17 is arranged on the water inlet pipe 16. A discharge pipe 18 is arranged at the bottom of the dosing box 4 for discharging the solution, and a valve 19 is arranged on the discharge pipe.
[0029] A medium water supply pipe 9 is provided on the upper side of the heat exchange chamber 3 for adding medium, and a plugging cover 10 is installed on the medium water supply pipe 9 for plugging the medium water supply pipe 9. A drain pipe 8 is provided at the bottom of the heat exchange chamber 3 for discharging the medium in the heat exchange chamber 3, and a drain valve 7 is installed on the drain pipe 8. An exhaust pipe 6 is provided on the upper side of the heat exchange chamber 3 for exhausting, and a pressure relief valve 5 is installed on the exhaust pipe 6.
[0030] A stirrer 15 and a dry powder dosing device 14 are installed on the top of the dosing box 4. The stirrer 15 is used to stir the solution in the dosing box 4, and the dry powder dosing device 14 is used to add medicine into the dosing box 4. The stirrer 15 is composed of a motor, a rotating shaft and blades; the motor is installed on the dosing box 4, the output end of the motor is connected to the rotating shaft, the rotating shaft extends to the inside of the dosing box 4, the blades are installed on the rotating shaft, and the blades are located in the dosing box 4.
[0031] This embodiment also adopts a PLC control box 13, which is electrically connected to the electric heating device 1, the pressure relief valve 5, the drain valve 7, the temperature sensor 11, the liquid level sensor 12, the dry powder dosing device 14, the agitator 15, the solenoid valve 17, the valve 19 and the monitoring instrument 20.
[0032] Example 2
[0033] Example 2 is a preferred example of Example 1.
[0034] The solubility of dry powder polyacrylamide is good at about 30℃, and it will not degrade. Above 40℃, the degradation of polyacrylamide solution will be accelerated, and the desludging and flocculation effect will be worse. The room temperature of the sewage treatment plant is about 10 degrees in winter. The solubility of dry powder polyacrylamide is poor. If dry powder polyacrylamide is added according to the standard concentration requirements, the formed solution will form flocs, block the pipeline and do not participate in desludging, increasing drug consumption. If the dosage of the agent is reduced, the concentration will not meet the desludging requirements. To solve this problem, an electric heating device 1, a medium heating chamber 2, and a heat exchange chamber 3 are installed on the periphery of the bottom of the dosing box 4, and a temperature sensor 11 and a liquid are installed on the top. The level sensor 12 feeds back the temperature and liquid level structure to the PLC control box 13, and the PLC control box 13 controls the electric heating device 1, which heats the heat exchange medium in the medium heating chamber 2. After the heat exchange medium is heated, the solution in the dosing box 4 is heated through the heat exchange chamber 3 to avoid local overheating of the solution in the dosing box 4, so that the internal solution is heated more evenly, and the temperature of the polyacrylamide solution is controlled at about 30°C to achieve the best dissolution effect, reduce the use of dry powder polyacrylamide, thereby saving medicines in winter, reducing the unit consumption of production medicines, and achieving the purpose of energy saving and efficiency improvement.
[0035] A medium water supply pipe 9 is provided at the upper left part of the heat exchange chamber 3, and a drainage pipe 8 is provided at the bottom to facilitate the replacement of the heat exchange medium. The heat exchange medium preferably uses tap water filtered by a water filter.
[0036] The solubility of polyacrylamide solution will increase with the increase of temperature, but it cannot exceed 40°C. If it exceeds this temperature, it will gradually degrade and the efficacy will decrease. In addition, polyacrylamide solution has a certain corrosiveness to metals. The use of conventional heating tubes and other heating methods will cause ionization corrosion and failure after a period of use, and there is also a risk of leakage. The heating method using the electric heating device 1 and the heat exchange chamber 3 can avoid the corrosion of the heating tube heating method and cause failure.
[0037] Working process:
[0038] After the start button of the PLC control box 13 is activated, the solenoid valve 17 is opened, and water is added to the dosing box 4. After the water level reaches the set height, the liquid level sensor 12 feeds back to the PLC control box 13, and the PLC control box 13 closes the solenoid valve 17 to stop adding water, and starts the agitator 15 and the electric heating device 1 at the same time. The temperature detected by the temperature sensor 12 can be displayed in real time on the monitor 20. When the water temperature reaches 25°C, the temperature sensor 11 feeds back data to the PLC control box 13, and the PLC control box 13 starts the dry powder dosing device 14 and starts to add dry powder polyacrylamide to the dosing box 4. The dosing is stopped after the set dose is reached. During the heating process, if the water temperature is higher than 30 degrees or the liquid level is lower than the set value, the heating is stopped. At the same time, the heating set temperature of the electric heating device 1 can be manually adjusted through the monitor 20. Once the temperature is adjusted through the monitor 20, the PLC control box 13 will immediately send a heating signal to the electric heating device 1 to ensure the efficacy of the polyacrylamide solution.
[0039] In the description of the present application, it should be understood that the terms "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside", etc., indicating orientations or positional relationships, are based on the orientations or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present application and simplifying the description, and do not indicate or imply that the referred device or element must have a specific orientation, be constructed and operated in a specific orientation, and therefore should not be understood as a limitation on the present application.
[0040] The above describes the specific embodiments of the present invention. It should be understood that the present invention is not limited to the above specific embodiments, and those skilled in the art can make various changes or modifications within the scope of the claims, which does not affect the essence of the present invention. In the absence of conflict, the embodiments of the present application and the features in the embodiments can be combined with each other at will.
Claims
1. A dry powder polyacrylamide solution constant temperature heating device, characterized in that: include: An electric heating device (1), a medium heating chamber (2), a heat exchange chamber (3), a drug adding box (4), a temperature sensor (11), a liquid level sensor (12), and a PLC control box (13); The heat exchange chamber (3) is arranged outside the medicine adding box (4), the heat exchange chamber (3) is connected to the electric heating device (1), and the medium heating chamber (2) is arranged between the electric heating device (1) and the heat exchange chamber (3); The temperature sensor (11) and the liquid level sensor (12) are installed on one side of the medicine adding box (4), and the temperature sensor (11) and the liquid level sensor (12) are connected to the PLC control box (13).
2. The constant temperature heating device for dry powder polyacrylamide solution according to claim 1, characterized in that: A water inlet pipe (16) is installed on the medicine adding box (4), a solenoid valve (17) is arranged on the water inlet pipe (16), and the solenoid valve (17) is connected to the PLC control box (13).
3. The constant temperature heating device for dry powder polyacrylamide solution according to claim 1, characterized in that: A drainage pipe (8) is provided at the bottom of the heat exchange chamber (3), and a drainage valve (7) is installed on the drainage pipe (8).
4. The dry powder polyacrylamide solution constant temperature heating device according to claim 1, characterized in that: The dosing box (4) is equipped with a stirrer (15) and a dry powder dosing device (14), and the stirrer (15) and the dry powder dosing device (14) are connected to the PLC control box (13).
5. The dry powder polyacrylamide solution constant temperature heating device according to claim 1, characterized in that: A discharge pipe (18) is provided at the bottom of the medicine adding box (4), and a valve (19) is installed on the discharge pipe.
6. The constant temperature heating device for dry powder polyacrylamide solution according to claim 1, characterized in that: A monitoring instrument (20) is installed outside the medicine adding box (4), and the line inlet end of the monitoring instrument (20) is electrically connected to the temperature sensor (11).
7. The constant temperature heating device for dry powder polyacrylamide solution according to claim 1, characterized in that: An exhaust pipe (6) is provided on the heat exchange chamber (3), and a pressure relief valve (5) is installed on the exhaust pipe (6).
8. The constant temperature heating device for dry powder polyacrylamide solution according to claim 1, characterized in that: The heat exchange chamber (3) is provided with a medium water supply pipe (9), and a blocking cover (10) is installed on the medium water supply pipe (9).
9. The constant temperature heating device for dry powder polyacrylamide solution according to claim 4, characterized in that: The stirrer (15) is composed of a motor, a rotating shaft and blades; The motor is mounted on the medicine adding box (4), the output end of the motor is connected to the rotating shaft, the rotating shaft extends into the interior of the medicine adding box (4), the blades are mounted on the rotating shaft, and the blades are located in the medicine adding box (4).
10. A sewage desludging system, characterized in that: The sewage desludging system adopts the dry powder polyacrylamide solution constant temperature heating device according to any one of claims 1 to 9.
Citation Information
Cited By
Sea water desalination impurity pretreatment system and process
CN120483471A
A seawater desalination impurity pretreatment system and process
CN120483471B
